Federal contractor · NEW YORK, NY

CERAMEDIX HOLDING, LLC

CERAMEDIX HOLDING, LLC received $1.5M in federal contract obligations in FY2026, on 2 awards (+18% vs FY2025). Since FY2020: $10.2M. Its largest customer was National Institutes of Health ($1.5M).

Obligations · FY2026
$1.5M
New awards
2
Sole-source
0.0%
Single offer
0.0%
UEI
JLZSJRJVKJ49
Other than small business

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 4.5MFY2020
  2. 0FY2022
  3. 1.5MFY2023
  4. 1.4MFY2024
  5. 1.3MFY2025
  6. 1.5MFY2026

Top buying agencies

Obligations in FY2026.

  1. 2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$1.5M100%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. National Institutes of Health· New York County, NY· Research & development· Jun 29, 2023 – Jul 20, 2026· 75N93023C00015
  2. National Institutes of Health· New York County, NY· Research & development· Jun 24, 2026 – Jun 24, 2026· 75N93026C00007

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

CERAMEDIX HOLDING, LLC received $0 in federal assistance in FY2026, on 1 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
1
Since FY2021
$3M

Assistance by fiscal year

  1. 0FY2021
  2. 1MFY2023
  3. 1MFY2024
  4. 993KFY2025
  5. 0FY2026

Largest awards

  1. 93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 28, 2021 – Nov 13, 2025· R44AI106283

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

By fiscal year

  • FY2023: $1.1M paid out · $0 received
  • FY2024: $1M paid out · $0 received
  • FY2025: $1M paid out · $0 received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

2 companies · $3.2M reported

  1. NEW YORK, NY · 8 subawards · Scientific research and development services
  2. BETHESDA, MD · 4 subawards · Scientific research and development services

Primes that pay it

No prime reported paying it.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. AN2 THERAPEUTICS, INC$4.3M−100% in FY2026
    MENLO PARK, CA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. LYMPHATECH, INC$4.1M−100% in FY2026
    ATLANTA, GA · 98% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. NEW YORK, NY · 98% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.